Brief: Harvard Bioscience Inc Reports Q4 Loss Per Share Of $0.04

Harvard Bioscience

09/03/2023 12:31

March 9 (Reuters) - Harvard Bioscience Inc  HBIO.O :
    * HARVARD BIOSCIENCE ANNOUNCES FOURTH QUARTER 2022 FINANCIAL
RESULTS
    * Q4 REVENUES WERE $28.4 MILLION, DOWN 14%
    * Q4 LOSS PER SHARE $0.04
    * Q4 DILUTED ADJUSTED EARNINGS PER SHARE $ 0.04
    * Q4 EARNINGS PER SHARE VIEW $0.03, REVENUE VIEW $30.3
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7XgvyC 
Further company coverage:  HBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;;))